Works matching AU Chapman, M. John

Results: 78

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.

Published in:

Nature Structural & Molecular Biology, 2011, v. 18, n. 4, p. 416, doi. 10.1038/nsmb.2028

By:

Huang, Rong;
Silva, R. A. Gangani D.;
Jerome, W. Gray;
Kontush, Anatol;
Chapman, M. John;
Curtiss, Linda K.;
Hodges, Timothy J.;
Davidson, W. Sean

Publication type:

Article

Blood Pressure-Lowering Response to Amlodipine as a Determinant of the Antioxidative Activity of Small, Dense HDL3.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 317, doi. 10.2165/11592280-000000000-00000

By:

Hansel, Boris;
Girerd, Xavier;
Bonnefont-Rousselot, Dominique;
Bittar, Randa;
Chantepie, Sandrine;
Orsoni, Alexina;
Bruckert, Eric;
Chapman, M. John;
Kontush, Anatol

Publication type:

Article

Banking Ratios (Book).

Published in:

1931

By:

Chapman, John M.

Publication type:

Book Review

Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 10, p. 4963, doi. 10.1210/jc.2004-0305

By:

HANSEL, BORIS;
GIRAL, PHILIPPE;
NOBECOURT, ESTELLE;
CHANTEPIE, SANDRINE;
BRUCKER, ERIC;
CHAPMAN, M. JOHN;
KONTUSH, ANATOL

Publication type:

Article

Action of Ciprofibrate in Type IIB Hyperlipoproteinemia: Modulation of the Atherogenic Lipoprotein Phenotype and Stimulation of High-Density Lipoprotein-Mediated Cellular Cholesterol Efflux.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 8, p. 3738, doi. 10.1210/jc.2003-030191

By:

GUERIN, MARYSE;
LE GOFF, WILFRIED;
FRISDAL, ERIC;
SCHNEIDER, SÉVERINE;
MILOSAVLJEVIC, DRAGANA;
BRUCKERT, ERIC;
CHAPMAN, M. JOHN

Publication type:

Article

Atorvastatin Reduces Postprandial Accumulation and Cholesteryl Ester Transfer Protein-Mediated Remodeling of Triglyceride-Rich Lipoprotein Subspecies in Type IIB Hyperlipidemia.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 11, p. 4991, doi. 10.1210/jc.2002-020298

By:

GUERIN, MARYSE;
EGGER, PASCAL;
LE GOFF, WILFRIED;
SOUDANT, CÉLINE;
DUPUIS, REYNALD;
CHAPMAN, M. JOHN

Publication type:

Article

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Published in:

Journal of Internal Medicine, 2006, v. 259, n. 3, p. 247, doi. 10.1111/j.1365-2796.2006.01616.x

By:

Barter, P. J.;
Ballantyne, C. M.;
Carmena, R.;
Cabezas, M. Castro;
Chapman, M. John;
Couture, P.;
de Graaf, J.;
Durrington, P. N.;
Faergeman, O.;
Frohlich, J.;
Furberg, C. D.;
Gagne, C.;
Haffner, S. M.;
Humphries, S. E.;
Jungner, I.;
Krauss, R. M.;
Kwiterovich, P.;
Marcovina, S.;
Packard, C. J.;
Pearson, T. A.

Publication type:

Article

Oxidizability of Atherogenic Low-Density Lipoprotein Subspecies in Severe Familial Hypercholesterolemia: Impact of Long-Term Low-Density Lipoprotein Apheresis.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2000, v. 5, n. 2, p. 87, doi. 10.1053/XV.2000.5588

By:

Lepage, Sylvie;
Nigon, Fabienne;
Bonnefont-Rousselot, Dominique;
Assogba, Ubald;
Goulinet, Sylvie;
Chancharme, Laurent;
Delattre, Jacques;
Bruckert, Eric;
Chapman, M. John

Publication type:

Article

Cholesterol, atherosclerosis, ischemic heart disease, and stroke.

Published in:

1970

By:

Dayton, Seymour;
Chapman, John M.;
Pearce, Morton Lee;
Popjak, George J.;
Dayton, S;
Chapman, J M;
Pearce, M L;
Popják, G J

Publication type:

journal article

High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049336

By:

Chantepie, Sandrine;
Bochem, Andrea E.;
Chapman, M. John;
Hovingh, G. Kees;
Kontush, Anatol

Publication type:

Article

Low Density Lipoproteins as Circulating Fast Temperature Sensors.

Published in:

PLoS ONE, 2008, v. 3, n. 12, p. 1, doi. 10.1371/journal.pone.0004079

By:

Prassl, Ruth;
Pregetter, Magdalena;
Amenitsch, Heinz;
Kriechbaum, Manfred;
Schwarzenbacher, Robert;
Chapman, John M.;
Laggner, Peter

Publication type:

Article

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients.

Published in:

Diabetes & Vascular Disease Research, 2008, v. 5, n. 4, p. 319, doi. 10.3132/dvdr.2008.046

By:

Fruchart, Jean-Charles;
Sacks, Frank M;
Hermans, Michel P;
Assmann, Gerd;
Brown, W Virgil;
Ceska, Richard;
Chapman, M John;
Dodson, Paul M;
Fioretto, Paola;
Ginsberg, Henry N;
Kadowaki, Takashi;
Lablanche, Jean-Marc;
Marx, Nikolaus;
Plutzky, Jorge;
Reiner, Zeljko;
Rosenson, Robert S;
Staels, Bart;
Stock, Jane K;
Sy, Rody;
Wanner, Christoph

Publication type:

Article

Metabolic syndrome and type 2 diabetes: lipid and physiological consequences.

Published in:

Diabetes & Vascular Disease Research, 2007, v. 4, n. 3S, p. S5, doi. 10.3132/dvdr.2007.050

By:

Chapman, M John

Publication type:

Article

The effects of fibrates on lipid metabolism and inflammation in type 2 diabetes.

Published in:

Diabetes & Vascular Disease Research, 2006, v. 3, n. 2S, p. S6, doi. 10.1177/147916410600300103

By:

Chapman, M John

Publication type:

Article

Introduction.

Published in:

Diabetes & Vascular Disease Research, 2006, v. 3, n. 2S, p. S1, doi. 10.3132/dvdr.2006.021

By:

Steiner, George;
Chapman, M John

Publication type:

Article

Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment.

Published in:

Diabetes & Vascular Disease Research, 2006, v. 3, n. 2SA, p. S1, doi. 10.3132/dvdr.2006.011

By:

Pedersen, Terje R;
Assmann, Gerd;
Bassand, Jean-Pierre;
Chapman, M John;
Erbel, Raimund;
Sirtori, Cesare

Publication type:

Article

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

Published in:

European Heart Journal, 2010, v. 31, n. 2, p. 149, doi. 10.1093/eurheartj/ehp399

By:

Chapman, M. John;
Le Goff, Wilfried;
Guerin, Maryse;
Kontush, Anatol

Publication type:

Article

Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides.

Published in:

FASEB Journal, 2003, v. 17, n. 1, p. 88, doi. 10.1096/fj.02-0293fje

By:

Kontush, Anatol;
Chancharme, Laurent;
Escargueil‐Blanc, Isabelle;
Therond, Patrice;
Salvayre, Robert;
Nègre‐Salvayre, Anne;
Chapman, M. John

Publication type:

Article

Wytyczne ESC/EAS dotyczące leczenia zaburzeń lipidowych w 2016 roku.

Published in:

Polish Heart Journal / Kardiologia Polska, 2016, v. 74, n. 11, p. 1234, doi. 10.5603/KP.2016.0157

By:

Catapano, Alberico L.;
Graham, Ian;
De Backer, Guy;
Wiklund, Olov;
Chapman, M. John;
Drexel, Heinz;
Hoes, Arno W.;
Jennings, Catriona S.;
Landmesser, Ulf;
Pedersen, Terje R.;
Reiner, Željko;
Riccardi, Gabriele;
Taskinen, Marja-Riita;
Tokgozoglu, Lale;
Verschuren, W. M. Monique;
Vlachopoulos, Charalambos;
Wood, David A.;
Zamorano, Jose Luis;
Cooney, Marie-Therese

Publication type:

Article

The year in cardiology 2015: prevention.

Published in:

Egyptian Heart Journal, 2016, v. 68, n. 4, p. 291, doi. 10.1016/j.ehj.2016.11.006

By:

Chapman, M. John;
Blankenberg, Stefan;
Landmesser, Ulf

Publication type:

Article

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.

Published in:

2017

By:

Ference, Brian A.;
Kastelein, John J. P.;
Ginsberg, Henry N.;
Chapman, M. John;
Nicholls, Stephen J.;
Ray, Kausik K.;
Packard, Chris J.;
Laufs, Ulrich;
Brook, Robert D.;
Oliver-Williams, Clare;
Butterworth, Adam S.;
Danesh, John;
Smith, George Davey;
Catapano, Alberico L.;
Sabatine, Marc S.

Publication type:

journal article

Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues.

Published in:

Journal of Clinical Investigation, 2006, v. 116, n. 10, p. 2767, doi. 10.1172/JCI26893

By:

Huby, Thierry;
Doucet, Chantal;
Dachet, Christiane;
Ouzilleau, Betty;
Ueda, Yukihiko;
Afzal, Veena;
Rubin, Edward;
Chapman, M. John;
Lesnik, Philippe

Publication type:

Article

Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues.

Published in:

2006

By:

Huby, Thierry;
Doucet, Chantal;
Dachet, Christiane;
Ouzilleau, Betty;
Ueda, Yukihiko;
Afzal, Veena;
Rubin, Edward;
Chapman, M. John;
Lesnik, Philippe

Publication type:

journal article

Ghidul Societății Europene de Cardiologie (ESC)/Societății Europene de Ateroscleroză (EAS) pentru diagnosticul şi tratamentul dislipidemiilor 2019: modificările lipidice în vederea reducerii riscului cardiovascular.

Published in:

Romanian Journal of Cardiology, 2020, v. 30, n. 2, p. 263

By:

Mach, Francois;
Baigent, Colin;
Catapano, Alberico L.;
Koskinas, Konstantinos C.;
Casula, Manuela;
Badimon, Lina;
Chapman, M. John;
De Backer, Guy G.;
Delgado, Victoria;
Ference, Brian A.;
Graham, Ian M.;
Halliday, Alison;
Landmesser, Ulf;
Mihaylova, Borislava;
Pedersen, Terje R.;
Riccardi, Gabriele;
Richter, Dimitrios J.;
Sabatine, Marc S.;
Taskinen, Marja-Riitta;
Tokgozoglu, Lale

Publication type:

Article

The year in cardiology 2015: prevention.

Published in:

Romanian Journal of Cardiology, 2016, v. 26, n. 4, p. 423

By:

Chapman, M. John;
Blankenberg, Stefan;
Landmesser, Ulf

Publication type:

Article

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society.

Published in:

European Heart Journal, 2021, v. 42, n. 47, p. 4791, doi. 10.1093/eurheartj/ehab551

By:

Ginsberg, Henry N;
Packard, Chris J;
Chapman, M John;
Borén, Jan;
Aguilar-Salinas, Carlos A;
Averna, Maurizio;
Ference, Brian A;
Gaudet, Daniel;
Hegele, Robert A;
Kersten, Sander;
Lewis, Gary F;
Lichtenstein, Alice H;
Moulin, Philippe;
Nordestgaard, Børge G;
Remaley, Alan T;
Staels, Bart;
Stroes, Erik S G;
Taskinen, Marja-Riitta;
Tokgözoğlu, Lale S;
Tybjaerg-Hansen, Anne

Publication type:

Article

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Published in:

European Heart Journal, 2020, v. 41, n. 24, p. 2313, doi. 10.1093/eurheartj/ehz962

By:

Borén, Jan;
Chapman, M John;
Krauss, Ronald M;
Packard, Chris J;
Bentzon, Jacob F;
Binder, Christoph J;
Daemen, Mat J;
Demer, Linda L;
Hegele, Robert A;
Nicholls, Stephen J;
Nordestgaard, Børge G;
Watts, Gerald F;
Bruckert, Eric;
Fazio, Sergio;
Ference, Brian A;
Graham, Ian;
Horton, Jay D;
Landmesser, Ulf;
Laufs, Ulrich;
Masana, Luis

Publication type:

Article

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.

Published in:

European Heart Journal, 2020, v. 41, n. 24, p. 2304, doi. 10.1093/eurheartj/ehz778

By:

Boden, William E;
Bhatt, Deepak L;
Toth, Peter P;
Ray, Kausik K;
Chapman, M John;
Lüscher, Thomas F

Publication type:

Article

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS).

Published in:

European Heart Journal, 2020, v. 41, n. 1, p. 111, doi. 10.1093/eurheartj/ehz455

By:

Mach, François;
Baigent, Colin;
Catapano, Alberico L;
Koskinas, Konstantinos C;
Casula, Manuela;
Badimon, Lina;
Chapman, M John;
Backer, Guy G De;
Delgado, Victoria;
Ference, Brian A;
Graham, Ian M;
Halliday, Alison;
Landmesser, Ulf;
Mihaylova, Borislava;
Pedersen, Terje R;
Riccardi, Gabriele;
Richter, Dimitrios J;
Sabatine, Marc S;
Taskinen, Marja-Riitta;
Tokgozoglu, Lale

Publication type:

Article

Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine.

Published in:

European Heart Journal, 2019, v. 40, n. 33, p. 2825, doi. 10.1093/eurheartj/ehy479

By:

Laufs, Ulrich;
Dent, Ricardo;
Kostenuik, Paul J;
Toth, Peter P;
Catapano, Alberico Luigi;
Chapman, M John

Publication type:

Article

New prospects for PCSK9 inhibition?

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2600, doi. 10.1093/eurheartj/ehy147

By:

Landmesser, Ulf;
Chapman, M John;
Stock, Jane K;
Amarenco, Pierre;
Belch, Jill J F;
Borén, Jan;
Farnier, Michel;
Ference, Brian A;
Gielen, Stephan;
Graham, Ian

Publication type:

Article

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.

Published in:

European Heart Journal, 2018, v. 39, n. 14, p. 1131, doi. 10.1093/eurheartj/ehx549

By:

Landmesser, Ulf;
Chapman, M John;
Stock, Jane K;
Amarenco, Pierre;
Belch, Jill J F;
Borén, Jan;
Farnier, Michel;
Ference, Brian A;
Gielen, Stephan;
Graham, Ian

Publication type:

Article

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: ameta-analysis of individual patient data.

Published in:

European Heart Journal, 2018, v. 39, n. 5, p. 374, doi. 10.1093/eurheartj/ehx661

By:

Harvey, Philip D;
Sabbagh, Marwan N;
Harrison, John E;
Ginsberg, Henry N;
Chapman, M John;
Manvelian, Garen;
Moryusef, Angele;
Mandel, Jonas;
Farnier, Michel

Publication type:

Article

Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I.

Published in:

Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 3, p. 608, doi. 10.1111/j.1582-4934.2009.00713.x

By:

de Souza, Juliana A.;
Vindis, Cecile;
Nègre-Salvayre, Anne;
Rye, Kerry-Anne;
Couturier, Martine;
Therond, Patrice;
Chantepie, Sandrine;
Salvayre, Robert;
Chapman, M. John;
Kontush, Anatol

Publication type:

Article

HDL-targeted therapies: progress, failures and future.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 6, p. 445, doi. 10.1038/nrd4279

By:

Kingwell, Bronwyn A.;
Chapman, M. John;
Kontush, Anatol;
Miller, Norman E.

Publication type:

Article

Functional interaction between −629C/A, −971G/A and −1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.

Published in:

Human Molecular Genetics, 2005, v. 14, n. 18, p. 2607, doi. 10.1093/hmg/ddi291

By:

Frisdal, Eric;
Klerkx, Anke H.E.M.;
Goff, Wilfried Le;
Tanck, Michael W.T.;
Lagarde, Jean-Pierre;
Jukema, J. Wouter;
Kastelein, John J.P.;
Chapman, M. John;
Guerin, Maryse

Publication type:

Article

HDL particle subpopulations: Focus on biological function.

Published in:

Biofactors, 2015, v. 41, n. 2, p. 67, doi. 10.1002/biof.1202

By:

Rached, Fabiana H.;
Chapman, M. John;
Kontush, Anatol

Publication type:

Article

Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab.

Published in:

Proteomics - Clinical Applications, 2016, v. 10, n. 2, p. 183, doi. 10.1002/prca.201500036

By:

Lee, Janet S.;
Chapman, M. John;
Piraino, Paolo;
Lamerz, Jens;
Schindler, Thomas;
Cutler, Paul;
Dernick, Gregor

Publication type:

Article

Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.

Published in:

Clinical Chemistry & Laboratory Medicine, 2004, v. 42, n. 2, p. 121, doi. 10.1515/CCLM.2004.024

By:

Beaudeux, Jean-Louis;
Giral, Philippe;
Bruckert, Eric;
Foglietti, Marie-José;
Chapman, M. John

Publication type:

Article

Plant Sterol-Enriched Margarine Lowers Plasma LDL in Hyperlipidemic Subjects with low Cholesterol Intake: Effect of Fibrate Treatment.

Published in:

Clinical Chemistry & Laboratory Medicine, 2001, v. 39, n. 7, p. 634

By:

Nigon, Fabienne;
Serfaty-Lacrosnière, Catherine;
Beucler, Isabel;
Chauvois, Dominique;
Neveu, Carol;
Giral, Philippe;
Chapman, M. John;
Bruckert, Eric

Publication type:

Article

Paraoxonase as a Risk Marker for Cardiovascular Disease: Facts and Hypotheses.

Published in:

Clinical Chemistry & Laboratory Medicine, 1998, v. 36, n. 7, p. 431

By:

Laplaud, P. Michel;
Dantoine, Thierry;
Chapman, M. John

Publication type:

Article

Editorial.

Published in:

1989

By:

Chapman, John W. M.

Publication type:

Editorial

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.

Published in:

European Heart Journal, 2017, v. 38, n. 29, p. 2245, doi. 10.1093/eurheartj/ehw480

By:

Landmesser, Ulf;
Chapman, M. John;
Farnier, Michel;
Gencer, Baris;
Gielen, Stephan;
Hovingh, G. Kees;
Lüscher, Thomas F.;
Sinning, David;
Tokgözoğlu, Lale;
Wiklund, Olov;
Zamorano, Jose Luis;
Pinto, Fausto J.;
Catapano, Alberico L.

Publication type:

Article

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Published in:

European Heart Journal, 2016, v. 37, n. 39, p. 2999, doi. 10.1093/eurheartj/ehw272

By:

Catapano, Alberico L.;
Graham, Ian;
De Backer, Guy;
Wiklund, Olov;
Chapman, M. John;
Drexel, Heinz;
Hoes, Arno W.;
Jennings, Catriona S.;
Landmesser, Ulf;
Pedersen, Terje R.;
Reiner, Željko;
Riccardi, Gabriele;
Taskinen, Marja-Riita;
Tokgozoglu, Lale;
Verschuren, W. M. Monique;
Vlachopoulos, Charalambos;
Wood, David A.;
Zamorano, Jose Luis;
Cooney, Marie-Therese;
Badimon, Lina

Publication type:

Article

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points--a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

Published in:

European Heart Journal, 2016, v. 37, n. 25, p. 1944, doi. 10.1093/eurheartj/ehw152

By:

Nordestgaard, Børge G.;
Langsted, Anne;
Mora, Samia;
Kolovou, Genovefa;
Baum, Hannsjörg;
Bruckert, Eric;
Watts, Gerald F.;
Sypniewska, Grazyna;
Wiklund, Olov;
Borén, Jan;
Chapman, M. John;
Cobbaert, Christa;
Descamps, Olivier S.;
von Eckardstein, Arnold;
Kamstrup, Pia R.;
Pulkki, Kari;
Kronenberg, Florian;
Remaley, Alan T.;
Rifai, Nader;
Ros, Emilio

Publication type:

Article

The year in cardiology 2015: prevention.

Published in:

European Heart Journal, 2016, v. 37, n. 6, p. 510, doi. 10.1093/eurheartj/ehv721

By:

Chapman, M. John;
Blankenberg, Stefan;
Landmesser, Ulf

Publication type:

Article

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Published in:

European Heart Journal, 2015, v. 36, n. 36, p. 2425, doi. 10.1093/eurheartj/ehv157

By:

Wiegman, Albert;
Gidding, Samuel S.;
Watts, Gerald F.;
John Chapman, M.;
Ginsberg, Henry N.;
Cuchel, Marina;
Ose, Leiv;
Averna, Maurizio;
Boileau, Catherine;
Borén, Jan;
Bruckert, Eric;
Catapano, Alberico L.;
Defesche, Joep C.;
Descamps, Olivier S.;
Hegele, Robert A.;
Kees Hovingh, G.;
Humphries, Steve E.;
Kovanen, Petri T.;
Kuivenhoven, Jan Albert;
Masana, Luis

Publication type:

Article

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease.

Published in:

European Heart Journal, 2013, v. 34, n. 45, p. 3478

By:

Nordestgaard, Børge G.;
Chapman, M. John;
Humphries, Steve E.;
Ginsberg, Henry N.;
Masana, Luis;
Descamps, Olivier S.;
Wiklund, Olov;
Hegele, Robert A.;
Raal, Frederick J.;
Defesche, Joep C.;
Wiegman, Albert;
Santos, Raul D.;
Watts, Gerald F.;
Parhofer, Klaus G.;
Hovingh, G. Kees;
Kovanen, Petri T.;
Boileau, Catherine;
Averna, Maurizio;
Borén, Jan;
Bruckert, Eric

Publication type:

Article

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.

Published in:

European Heart Journal, 2013, v. 34, n. 41, p. 3182, doi. 10.1093/eurheartj/eht260

By:

Puri, Rishi;
Nissen, Steven E.;
Shao, Mingyuan;
Ballantyne, Christie M.;
Barter, Phillip J.;
Chapman, M. John;
Erbel, Raimund;
Libby, Peter;
Raichlen, Joel S.;
Uno, Kiyoko;
Kataoka, Yu;
Nicholls, Stephen J.

Publication type:

Article

Factors underlying regression of coronary atheroma with potent statin therapy.

Published in:

European Heart Journal, 2013, v. 34, n. 24, p. 1818, doi. 10.1093/eurheartj/eht084

By:

Puri, Rishi;
Nissen, Steven E.;
Ballantyne, Christie M.;
Barter, Phillip J.;
Chapman, M. John;
Erbel, Raimund;
Libby, Peter;
Raichlen, Joel S.;
St. John, Julie;
Wolski, Kathy;
Uno, Kiyoko;
Kataoka, Yu;
Nicholls, Stephen J.

Publication type:

Article